Τετάρτη 6 Σεπτεμβρίου 2017

GEIS-21: a multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: a report from the Spanish sarcoma group (GEIS)

GEIS-21: a multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: a report from the Spanish sarcoma group (GEIS)

British Journal of Cancer 117, 767 (5 September 2017). doi:10.1038/bjc.2017.252

Authors: J Mora, A Castañeda, S Perez-Jaume, A Lopez-Pousa, E Maradiegue, C Valverde, J Martin-Broto, X Garcia del Muro, O Cruz, J Cruz, J Martinez-Trufero, J Maurel, M A Vaz, E de Alava & C de Torres



http://ift.tt/2vClISA

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου